Autism Spectrum Disorder: Pathophysiology and Treatment Implications

Author(s): George Anderson.

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 41 , 2019

Become EABM
Become Reviewer

[1]
Anderson G, Medina SRB. Autism spectrum disorders: role of pre- and post-natal GammaDelta (γδ) T cells and immune regulation. Curr Pharm Des 2019; 25(41): 4321-30.
[2]
Beversdorf DQ, Stevens HE, Margolis KG, Van de Water J. Prenatal stress and maternal immune dysregulation in autism spectrum disorders: potential points for intervention. Curr Pharm Des 2019; 25(41): 4331-43.
[3]
Seo M, Anderson G. Gut-amygdala interactions in autism spectrum disorders: developmental roles via regulating mitochondria, exosomes, immunity and microRNAs. Curr Pharm Des 2019; 25(41): 4344-56.
[4]
Alzghoul L. Role of vitamin D in autism spectrum disorders. Curr Pharm Des 2019; 25(41): 4357-67.
[5]
Mahesh MV, Puthiripadath SS, Parakkal R, Ismail T, Ayyappan A. microRNAs in autism spectrum disorders. Curr Pharm Des 2019; 25(41): 4368-78.
[6]
Pinato L, Spilla CSG, Campos LMG, Markus RP, da Silveira Cruz-Machado S. Dysregulation of circadian rhythms in autism spectrum disorders. Curr Pharm Des 2019; 25(41): 4379-93.
[7]
Telias M. Pharmacological treatments for fragile X syndrome based on synaptic dysfunction. Curr Pharm Des 2019; 25(41): 4394-404.
[8]
Maes M, Anderson G, Medina SRB, Seo M, Ojala JO. Integrating autism spectrum disorder pathophysiology: mitochondria, vitamin A, CD38, oxytocin, serotonin and melatonergic alterations in the placenta and gut. Curr Pharm Des 2019; 25(41): 4405-20.
[9]
Kardani A, Soltani A, Sewell RDE, Shahrani M, Rafieian-Kopaei M. Neurotransmitter, antioxidant and anti-neuroinflammatory mechanistic potentials of herbal medicines in ameliorating autism spectrum disorder. Curr Pharm Des 2019; 25(41): 4421-9.
[10]
Pacheva I, Ivanov I. Targeted biomedical treatment for autism spectrum disorders. Curr Pharm Des 2019; 25(41): 4430-53.
[11]
Ruggieri V, Cuesta Gómez JL, Martínez MM, Arberas C. Aging and autism: understanding, intervention, and proposals to improve quality of life. Curr Pharm Des 2019; 25(41): 4454-61.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 41
Year: 2019
Page: [4319 - 4320]
Pages: 2
DOI: 10.2174/138161282541191230102715

Article Metrics

PDF: 20
HTML: 4